The higher NLR levels observed in patients with AD were associated with increased amyloid burden, but this association was no longer present after adjustment for age, sex, and ApoE4 status, thus potentially limiting the potential of NLR as a diagnostic biomarker in more advanced stages of the disease. The gene discussed is APOE; the disease is Alzheimer disease.